Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Delcath Systems Inc (DCTH)

Delcath Systems Inc (DCTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 345,371
  • Shares Outstanding, K 35,314
  • Annual Sales, $ 37,210 K
  • Annual Income, $ -26,390 K
  • EBIT $ 6 M
  • EBITDA $ 6 M
  • 60-Month Beta 0.41
  • Price/Sales 9.51
  • Price/Cash Flow N/A
  • Price/Book 3.08

Options Overview Details

View History
  • Implied Volatility 208.50% (+79.08%)
  • Historical Volatility 50.92%
  • IV Percentile 98%
  • IV Rank 84.91%
  • IV High 237.50% on 11/13/25
  • IV Low 45.27% on 08/21/25
  • Expected Move (DTE 11) 0.68 (7.05%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 45
  • Volume Avg (30-Day) 396
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 14,471
  • Open Int (30-Day) 18,455
  • Expected Range 8.96 to 10.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year 0.05
  • Growth Rate Est. (year over year) -220.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.12 +18.72%
on 11/20/25
10.14 -4.93%
on 12/05/25
+1.00 (+11.57%)
since 11/07/25
3-Month
8.12 +18.72%
on 11/20/25
12.70 -24.09%
on 10/16/25
-1.91 (-16.54%)
since 09/08/25
52-Week
8.12 +18.72%
on 11/20/25
18.23 -47.12%
on 05/20/25
-2.23 (-18.79%)
since 12/06/24

Most Recent Stories

More News
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication...

DCTH : 9.64 (-1.43%)
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program

Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath”) an interventional oncology company focused on the treatment of primary and metastatic cancers to the liver, today announced that its Board of Directors...

DCTH : 9.64 (-1.43%)
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication...

DCTH : 9.64 (-1.43%)
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the...

DCTH : 9.64 (-1.43%)
Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients

Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication...

DCTH : 9.64 (-1.43%)
Delcath Systems to Participate in Upcoming Investor Conferences

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following...

DCTH : 9.64 (-1.43%)
Delcath Systems Reports Third Quarter 2025 Results and Business Highlights

Conference Call Today at 8:30 a.m. Eastern Time

DCTH : 9.64 (-1.43%)
Delcath Systems to Host Third Quarter 2025 Earnings Call

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on November...

DCTH : 9.64 (-1.43%)
Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results

Conference Call October 20, 8:45am EST

DCTH : 9.64 (-1.43%)
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint

Conference Call October 20, 8:45am EST

DCTH : 9.64 (-1.43%)

Business Summary

Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver.

See More

Key Turning Points

3rd Resistance Point 10.12
2nd Resistance Point 10.00
1st Resistance Point 9.82
Last Price 9.64
1st Support Level 9.52
2nd Support Level 9.41
3rd Support Level 9.23

See More

52-Week High 18.23
Fibonacci 61.8% 14.37
Fibonacci 50% 13.17
Fibonacci 38.2% 11.98
Last Price 9.64
52-Week Low 8.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar